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The mammalian gene Nit1 (nitrilase-like protein 1) encodes a pro-
tein that is highly conserved in eukaryotes and is thought to act as
a tumor suppressor. Despite being ∼35% sequence identical to
ω-amidase (Nit2), the Nit1 protein does not hydrolyze efficiently
α-ketoglutaramate (a known physiological substrate of Nit2), and
its actual enzymatic function has so far remained a puzzle. In the
present study, we demonstrate that both the mammalian Nit1 and
its yeast ortholog are amidases highly active toward deaminated
glutathione (dGSH; i.e., a form of glutathione in which the free
amino group has been replaced by a carbonyl group). We further
show that Nit1-KO mutants of both human and yeast cells accu-
mulate dGSH and the same compound is excreted in large amounts
in the urine of Nit1-KO mice. Finally, we show that several mam-
malian aminotransferases (transaminases), both cytosolic and mi-
tochondrial, can form dGSH via a common (if slow) side-reaction
and provide indirect evidence that transaminases are mainly re-
sponsible for dGSH formation in cultured mammalian cells. Alto-
gether, these findings delineate a typical instance of metabolite
repair, whereby the promiscuous activity of some abundant en-
zymes of primary metabolism leads to the formation of a useless
and potentially harmful compound, which needs a suitable “repair
enzyme” to be destroyed or reconverted into a useful metabolite.
The need for a dGSH repair reaction does not appear to be limited
to eukaryotes: We demonstrate that Nit1 homologs acting as ex-
cellent dGSH amidases also occur in Escherichia coli and other
glutathione-producing bacteria.
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Genome sequencing has led to the identification of numerousproteins sharing significant sequence identity with enzymes,
but whose catalytic activity remains to be established. Knowing
the function of these putative enzymes, particularly if they are
highly conserved, may reveal important aspects of intermediary
metabolism that have remained unexplored until now. The pur-
pose of the present work was to determine the catalytic role of
nitrilase-like protein 1 (Nit1), a highly conserved protein with still
unknown function (1–6) but homologous to Nit2 (ω-amidase)
(5, 6), an enzyme whose activity is closely linked to transamination
reactions.
In fact, aminotransferases that use L-glutamine as a substrate
yield, as a product, the corresponding ketoacid, α-ketoglutaramate
(α-KGM) (Fig. 1A). Such a reaction is rendered metabolically
irreversible by the coupled activity of ω-amidase, which hydrolyzes
α-KGM to α-ketoglutarate (α-KG) and ammonia (Fig. 1A) (7–9).
In mammals, ω-amidase is encoded by the Nit2 gene (5, 6).
In addition to Nit2, the genomes of the most evolved eu-
karyotes contain almost invariably the gene Nit1, whose product
shows ∼35% sequence identity with Nit2. Compared with Nit2,
however, the Nit1 protein shows only weak ω-amidase activity
toward α-KGM (catalytic efficiency <0.1% of that of Nit2) (5).
The observation that in many invertebrates Nit1 is expressed as
a domain fused with a fragile histidine triad protein (Fhit,
suggested to act as a tumor suppressor in mammals) (1), has
fueled a substantial interest in deciphering the physiological
substrates of this enzyme. Galperin and Koonin even included
Nit1 among the “top 10” most attractive targets for functional
assignment (10, 11), assuming that clarification of its activity
could illuminate new aspects of biology. Despite all this interest,
the actual enzymatic function of Nit1 has so far remained
elusive.
Sequence comparisons and structural data indicate that the
residues of the Nit2 catalytic pocket that surround the substrate
α-KGM are conserved in Nit1. A major difference is, however,
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found in the subsite where the amido group of α-KGM is predicted
to bind, which is a quite small niche in the structure of Nit2, but a
much larger cavity in Nit1 (2, 4). These structural features suggest
that Nit1 serves to hydrolyze an α-KG or α-KGM derivative at-
tached to a rather large structure. Because no classic reaction of
intermediary metabolism leads to the formation of such com-
pounds, we considered the possibility that nonclassic compounds
could be formed by side reactions of classic enzymes of interme-
diary metabolism and that Nit1 would serve as a “metabolite repair”
enzyme.
Recent research has unveiled the importance of metabolite
repair in intermediary metabolism (12, 13). According to this
concept, enzymes of intermediary metabolism are not perfectly
specific and tend to act on intracellular compounds resembling
their true substrate. The products of these side reactions are
nonclassic metabolites, which in several cases need to be elimi-
nated or recycled by specific enzymes, called metabolite repair
enzymes (12). Deficiency in such enzymes causes accumulation
of the “abnormal” metabolite and may lead to disease, as in the
case of L-2-hydroxyglutaric aciduria (14, 15) or to major metabolic
perturbations because of enzyme inhibition (16). The increasing
rate at which repair enzymes are being discovered suggests that
a substantial fraction of currently “unclassified” enzymes (17),
encoded in eukaryotic and prokaryotic genomes, could play a
role in metabolite repair.
Conceivably, at least two types of reactions might lead to the
formation of bulky ω-derivatives of α-KG: (i) transamination reac-
tions leading to the conversion of glutathione (GSH) to a deami-
nated form (called deaminated GSH or dGSH in the present work)
(Fig. 1B); and (ii) the “erroneous” attachment of a CoA group to
α-KG by succinyl-CoA:glutarate-CoA transferase (SUGCT), which
would lead to α-ketoglutaryl–CoA (α-KG–CoA) (Fig. 1C). Our
purpose was to test these compounds as substrates for Nit1. In
this work, we provide evidence that mouse Nit1 (mmNit1) and its
Saccharomyces cerevisiae ortholog (scNit1; see Table 1 for the des-
ignation of the proteins investigated in the present work) are ex-
cellent dGSH amidases and that their inactivation leads to the
accumulation of dGSH in cell models as well as in vivo.
Results
Nit1 Efficiently Hydrolyzes the Amide Bond in dGSH. dGSH and
deaminated ophthalmic acid (dOA)—OA is a physiological tri-
peptide analog of GSH where the central cysteine is replaced by
2-aminobutyrate, a cysteine structural analog unable to form
disulfides—as well as α-KGM, were prepared by oxidation of the
appropriate compounds with snake venom L-amino acid oxidase,
an enzyme that displays broad specificity (18, 19), and subse-
quently separated from the parent compound by cation-exchange
chromatography (5). When dGSH and dOA were further puri-
fied by reverse-phase HPLC, both compounds eluted in two
Fig. 1. The Nit2 reaction and the working hypotheses tested in this work about Nit1 activity. (A) The known coupled reactions catalyzed by glutamine
transaminases and ω-amidase (Nit2). The transamination of glutamine yields α-KGM, the linear form of which equilibrates with a cyclic form (two potential
anomers). Nit2 catalyzes the hydrolysis of the open form to α-KG and ammonia. (B) An analogous process, in which the transamination of GSH to dGSH is
followed by hydrolysis of dGSH to α-KG and cysteinylglycine. (C) α-KG–CoA, formed by SUGCT (C7orf10), is another potential substrate for Nit1.
Table 1. Proteins investigated in the present work
Species
Gene reference
(DOE website)
Gene
symbol
Protein
designation
Mus musculus 639390753 Nit1 mmNit1
639398620 Nit2 mmNit2
Saccharomyces 638211686 NIT2 scNit1
cerevisiae 638212758 NIT3 scNit2
Escherichia coli 646917127 ybeM (ybl23) ecYbeM
646916767 yafV ecYafV
Yersinia 2638510043 y0194 yeNit1
enterocolitica 2638509534 No gene symbol yeYafV
Pseudomonas 2687301550 PA4475 paNit1
aeruginosa 2687297946 PA3797 paYafV
Synechocystis sp.
GT-S, PCC6803
651080170 sll0601 syNit1
Bifidobacterium
longum
2650840504 No gene symbol blYbeM
Staphylococcus
aureus
2511961111 amiE saYafV
Genes and protein sequences can be retrieved from the Department of
Energy (DOE) website (https://img.jgi.doe.gov/cgi-bin/mer/main.cgi). The des-
ignations for the bacterial proteins studied in this work other than E. coli
have been chosen based on their degree of identity with the mouse or E. coli
proteins (see SI Appendix, Fig. S14 and Table S3). For example, blYbeM shows
a higher degree of identity with ecYbeM than with mmNit1, mmNit2, or
ecYafV; similarly, paNit1 shows a higher degree of identity with mmNit1 than
with mmNit2, ecYbeM or ecYafV.
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different peaks, corresponding to the two anomeric forms of the
cyclized ketoacid. A peak attributable to the linear form was not
detectable, suggesting that, in analogy with the case of α-KGM
(20), such a linear form is largely unfavored for dGSH and dOA.
dGSH, in addition to the two anomeric peaks, presented addi-
tional peaks eluting later and corresponding to disulfides of
dGSH with GSH and with itself. Such additional peaks dis-
appeared if the sample was treated with excess DTT before
chromatography.
After purification, dGSH and dOA were tested as substrates
for the recombinant mouse enzymes (mmNit1 and mmNit2) and
for their yeast homologs, using a coupled assay with glutamate
dehydrogenase (GDH) that monitors the release of α-KG. As
shown in Table 2 and its legend, both dGSH and dOA are good
substrates for mmNit1 and scNit1, whereas α-KGM is a much
poorer substrate. Conversely, mmNit2 and its yeast counterpart
acted efficiently on the small substrate α-KGM but showed no
detectable activity toward the larger substrates derived from
GSH and OA.
Having established that the Nit1 activity releases α-KG from
dGSH and dOA, we also tested whether the other products of
these reactions are, respectively, cysteinylglycine and 2-amino-
butyrylglycine, as expected. Generation of stoichiometric amounts
of 2-aminobutyrylglycine from dOA was demonstrated by
N-labeling the reaction mixture with 6-aminoquinolyl-N-hydroxy-
succinimidyl carbamate (AQC) and identifying the AQC-derivative
of the dipeptide by reverse-phase HPLC (SI Appendix, Fig.
S1). For unknown reasons, we were unable to detect the
second product of dGSH cleavage by this method, but could
easily measure the formation of cysteinylglycine directly in the
reaction mixture, exploiting its known propensity to form a
thiazolidine adduct with pyridoxal 5′-phosphate (PLP) (21).
Because the formation of this adduct requires the presence of
both a free amino group and of a free thiol on the same
molecule (21), this technique confirmed that cysteinylglycine
was formed in stoichiometric amounts during dGSH cleavage
(SI Appendix, Fig. S2).
It is well established that ω-amidase acts on the linear form of
α-KGM (20), despite the fact that in solution this form is 300-
fold less abundant than the cyclic (lactam) forms (Fig. 1A). Be-
cause substituted derivatives of α-KGM also tend to cyclize, we
tested the effect of increasing mmNit1 concentrations on the rate
of dGSH hydrolysis. The measured reaction rate leveled off at
high enzyme concentration, implying that under those conditions
opening of the cyclic form becomes rate-limiting for the whole
process (SI Appendix, Fig. S3A). From this experiment, we
inferred an apparent first-order rate constant for ring opening of
0.26 min−1 at pH 7.2. By comparison, at the same pH, opening of
the α-KGM form occurs with an apparent first-order rate con-
stant of 0.0011 min−1 (20). This difference is likely attributable to
internal catalysis because of the presence of the thiol group and
of the glycine carboxylic group in dGSH. Consistent with this
interpretation, the corresponding opening of cyclic dOA appears
to be about 10-fold slower compared with dGSH (SI Appendix,
Fig. S3B).
With this information in hand, we designed experiments to
measure the catalytic parameters exhibited by mmNit1 and
its yeast ortholog (scNit1) under conditions where the opening
of the cyclic form is not rate limiting. As shown in Table 2,
the apparent catalytic efficiencies (kcat/KM) toward dGSH for
mmNit1and scNit1 are in the range 104 to 105 M−1·s−1, over
1,000-fold higher than those observed toward α-KGM. These
apparent kcat/KM values are also close to the “average” value
for metabolic enzymes (22). If one considers that the actual
substrate of these amidases is in fact the (minimally abundant)
linear form of dGSH, as shown above, the “correct” kcat/KM
values for mmNit1 and its yeast counterpart should greatly ex-
ceed 106 M−1·s−1.
dGSH Accumulates in Nit1-Deficient Model Cells and in the Urine of
Nit1-KO Mice. We prepared human cell lines (HAP1) deficient in
Nit1 and Nit2 by CrispR/Cas9 technology. We selected two
distinct Nit1-KO clones, targeted at two locations of the Nit1
gene by using different guide RNAs, as described in Materials
and Methods. Sequencing of the DNA indicated the presence of
mutations incompatible with the production of an active Nit1
protein in these clones (SI Appendix, Supplementary Materials
and Methods). Analysis of cell extracts by liquid chromatography-
mass spectrometry (LC/MS) indicated the presence of a peak
with the same exact m/z ratio and elution volume as dGSH (SI
Appendix, Fig. S4A). Analysis of samples derived from cells de-
ficient in Nit2 or from control cells revealed much lower
amounts of the same compound. Assuming a water cell volume
of 2.5 μL/mg protein, we estimated that the intracellular dGSH
Table 2. Observed rates and catalytic parameters for the reactions catalyzed by recombinant mouse Nit1 and
Nit2 and by their yeast orthologs
α-KGM or
dGSH
Activity at 80 μM
substrate (μmol·min−1·mg−1) Vmax* (μmol· min−1·mg−1) kcat (s−1) KM (μM) kcat/KM (M−1·s−1)
α-KGM
mmNit1 2.6 × 10−3 ± 3 × 10−4 — — — 18 ± 2†
scNit1 1.5 × 10−3 ± 2 × 10−4 — — — 12 ± 2†
mmNit2 4.3 ± 0.5 19.4 ± 1.4 10.7 ± 0.7 250 ± 40 43,000 ± 3,000
scNit2 1.6 ± 0.23 40.2 ± 1.5 23.5 ± 0.9 1,600 ± 200 14,700 ± 2,100
dGSH
mmNit1 0.8 ± 0.05 2.6 ± 0.4 1.6 ± 0.3 170 ± 60 9,400 ± 3,000
scNit1 2.7 ± 0.5 5.8 ± 0.5 3.6 ± 0.3 45 ± 6 80,000 ± 12,000
mmNit2 ≤3 × 10−4 — — — <3
scNit2 ≤1.6 × 10−4 — — — <2
Values are the average (± SEM) of at least three separate measurements. Activities were determined at pH 8.5 (30 °C) and at
enzyme concentrations calibrated to ensure that the spontaneous opening of the cyclic forms of the substrates was not rate-limiting
for the reaction measured. Details are provided inMaterials and Methods. Activities (μmol·min−1·mg−1) toward 80 μM dOA were 0.07 ±
0.01 (mmNit1), 0.85 ± 0.03 (scNit1), ≤2 × 10−4 (mmNit2) and ≤3 × 10−4 (scNit2).
*Specific activity at saturating concentration of substrate.
†kcat/KM corresponds to the initial slope of the Michaelis-Menten hyperbola. Because the activities of both mmNit1 and scNit1 toward
α-KGM increased linearly with substrate concentration up to at least 80 μM, kcat/KM values were estimated from the slopes of such
increases. Because of the very low activity of mmNit1 and scNit1 with α-KGM, enzyme concentrations in these experiments were in
the 0.5–1.5 μM range.
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accumulated to about 180 μM (i.e., at least sixfold higher than in
the controls). On the other hand, GSH levels did not vary sig-
nificantly between control cells and Nit1- or Nit2-deficient cells,
with estimated intracellular concentrations of ∼3.5 mM in all
cases (Fig. 2A).
We similarly found that a yeast strain deficient in the Nit1
ortholog (encoded by the NIT2 gene) (Table 1) accumulated
higher levels of dGSH than either the WT strain or the strain
deleted in the Nit2 ortholog (encoded by the NIT3 gene) (SI
Appendix, Fig. S4B). For yeast, unlike for HAP1 cells, estimates
of the intracellular levels of metabolites were based on direct cell
volume measurements by a Multisizer 3 Coulter Counter (Beckman
Coulter). The calculated intracellular concentration of dGSH
reached 28 μM, whereas it was three- to sevenfold lower in the
controls (Fig. 2B). The estimated intracellular concentration of
GSH was around 0.9 mM for yeast, and did not change signifi-
cantly between the KO mutant and the controls.
We also tested urine from a mouse Nit1-KO model (23). By
LC/MS we were able to demonstrate the presence of dGSH in
urine samples from these mice (Fig. 3); the concentration of
dGSH assessed by this technique was 1,260 ± 130 μmol·mmol
creatinine−1 (mean ± SEM, n = 4): that is, at least 15-fold higher
than that observed in the controls. In fact, the concentration of
dGSH in the urine of Nit1-KO mice was sufficiently high that it
could also be detected by a spectrophotometric assay, in which
the α-KG formation was measured through the coupled reac-
tions of Nit1 and GDH, in a cuvette containing a few microliters
of urine diluted in reaction buffer. The spectrophotometric assay
yielded concentrations of dGSH within twofold of those esti-
mated by LC/MS (687 ± 120 μmol·mmol creatinine−1).
Gas chromatography-mass spectrometry (GC/MS) analysis of
urine revealed the presence of a major peak occurring in the
urine samples of all tested Nit1-KO mice, but almost absent from
the urine of all control mice (Fig. 4 A and B). The MS spectrum
of this unknown compound presented the most intense ion
(presumably the molecular ion) at m/z 398. When we subjected
purified dGSH to the same GC/MS analysis, we observed the
appearance of a peak with the same elution time and MS spec-
trum (Fig. 4C). Analysis of the spectra indicated that this com-
pound corresponds to a trimethylsilyl (TMS) derivative of a
dehydrated, dethiolated form of dGSH, presumably generated
during derivatization (Fig. 4D and SI Appendix, Fig. S5). The
same m/z 398 compound was also observed in the GC/MS
analysis of extracts from Nit1-deficient HAP1 cell lines (SI Ap-
pendix, Fig. S6).
Formation of dGSH Is a Side Reaction of Numerous Transaminases.
The accumulation and excretion of dGSH in model systems
suggests that Nit1 is the only (or at least the main) enzyme ca-
pable of metabolizing this compound. However, it remains to be
established how dGSH is formed in vivo. To address this issue,
we investigated the capacity of transaminases to carry out trans-
amination reactions using GSH or OA as amino group donors.
We began by focusing on glutamine transaminase K (gene symbol
KYAT1), a rather promiscuous enzyme known to catalyze trans-
amination reactions with glutamine, as well as with a number of
other amino acids (24). Evidence that recombinant KYAT1 is also
able to react with GSH is shown in SI Appendix, Fig. S7A. Addi-
tion of GSH led to a progressive change in the enzyme spectrum
indicating the conversion of the protein-bound PLP cofactor to
pyridoxamine 5′-phosphate. No change took place in the absence
of GSH. Similar data were obtained when GSH was replaced
with OA.
HPLC analysis of reaction mixtures in which OA and
glyoxylate—which has the advantage of binding quite weakly to
glutamine transaminase K, limiting the phenomenon of sub-
strate inhibition observed with larger α-keto acid substrates (25,
26)—were incubated overnight with KYAT1 indicated the ap-
pearance of two peaks corresponding to dOA (SI Appendix,
Figs. S7B and S8). A similar experiment performed with GSH
resulted in the appearance of several peaks, corresponding to
a mixture of reduced dGSH and of disulfides resulting from
its reaction with GSH or with itself (SI Appendix, Figs. S7C
and S9).
To measure the slow formation of dGSH and dOA by
KYAT1 and by other transaminases, we used a coupled assay
with Nit1 and GDH. The assay worked well in a continuous
format (an example with the enzyme ornithine aminotransferase,
OAT, is shown in SI Appendix, Fig. S10). However, to minimize
artifacts because of contaminating NADH-oxidizing activities or
the regeneration of L-Glu by GDH, these coupled assays were
performed in a discontinuous fashion. This way we could com-
pare the side-activities leading to dGSH to more classic activities
for some representative mammalian transaminases (including
both cytosolic and mitochondrial examples) (27) (Table 3). Quite
remarkably, detectable activities were encountered in all cases,
although they were very small compared with the more classic
activities of these enzymes.
To further test whether dGSH in mammalian cells is mostly
formed through aminotransferase reactions, we cultured the
WT and Nit1-deficient HAP1 cell lines in the presence and in the
absence of aminooxyacetate (AOA), which is a general inhibitor of
Fig. 2. Accumulation of dGSH in Nit1-deficient HAP1 cells and in NIT2-
deficient yeast. (A) HAP1 cell extracts were prepared from two cell lines
deficient in Nit1, from one HAP1 cell line deficient in Nit2 and from three
control cell lines. Among these, two were cell lines that had been submitted
to the CrispR/Cas9 gene inactivation procedure, but yielding no modification
of the Nit1 gene; this was done to exclude the possibility of any off-target
effect of the guide RNAs used that may lead to dGSH accumulation. (B) WT
S. cerevisiae and mutants lacking either scNit1 (NIT2-KO) (Table 1) or scNit2
(NIT3-KO) were cultivated in minimal defined medium with 1% glucose.
Samples were collected after 15 h from starting the culture, corresponding
to the late exponential growth phase. Intracellular metabolites were
extracted, analyzed by LC/MS and dGSH and GSH were quantitated as above.
Intracellular concentrations were calculated as detailed in Materials and
Methods. Means ± SEM of three biological replicates are shown. A modest
but statistically significant (P < 0.05) increase in the intracellular dGSH con-
centration was reproducibly observed in NIT3-KO cells compared with WT.
The NIT3-KO cells appeared to accumulate substantial amounts of α-KGM
(≥300 μM), and it is possible that the observed increase in dGSH is secondary
to this accumulation.
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PLP-dependent enzymes, including transaminases (28). As shown
in SI Appendix, Fig. S11, the accumulation of dGSH in HAP1 cells
decreased in a dose-dependent manner when the cells were
cultivated for 24 h with 50, 100, or 200 μM AOA added to the
culture medium. These data support the hypothesis that ami-
notransferase activity is necessary to form dGSH in vivo.
Nit1 Localizes in Both the Cytosol and the Mitochondria of Mammalian
Cells. Databases indicate the existence, both in mouse and in
humans, of two types of Nit1 transcripts, which differ by their
length at their 5′ end. This suggests that Nit1 can be translated
from two distinct, conserved AUGs, resulting in proteins that
differ by the presence (mNit1, NP_036179.1) or the absence
(cNit1; NP_001229509.1) of a mitochondrial propeptide sequence.
Chinese hamster ovary cells were transfected so as to express
either form of the Nit1 protein fused at the C terminus to GFP.
The transfected cells expressing mNit1-GFP showed localization
of the protein mainly in the mitochondria but also in the cytosol,
whereas those expressing cNit1-GFP showed exclusively a cyto-
solic localization (SI Appendix, Fig. S12). Overall, this double
localization of Nit1 is in agreement with the results of earlier
studies (23, 29) and is consistent with a role of the enzyme in
recycling a side product of transaminases, which are abundant in
both the cytosol and the mitochondria.
Activity of Nit1 and Nit2 Toward α-KG–CoA and Other Potential
Substrates. As noted in the introduction, an alternative repair
function for Nit1 could be the hydrolysis of α-KG–CoA. An en-
zyme capable of producing α-KG–CoA is SUGCT [the product
of a gene also known as C7orf10 (30)]. This mitochondrial en-
zyme reversibly exchanges CoA between a dicarboxylyl-CoA and
a dicarboxylate. Its main physiological substrates are succinyl-
CoA and glutarate, but in vitro it was shown to use, with lower
efficiency, various other dicarboxylates, including α-KG (30).
By using the recombinant human SUGCT, we were able to
produce α-KG–CoA and to show that it is hydrolyzed by mmNit1.
In fact, among all dicarboxylyl-CoAs that are made by SUGCT,
α-KG–CoA was found to be the best mmNit1 substrate, empha-
sizing that the presence of a keto function on the α-carbon is es-
sential for substrate recognition (SI Appendix, Fig. S13A). However,
mmNit2 also cleaved α-KG–CoA at almost the same rate as that
observed with mmNit1 (SI Appendix, Fig. S13B), indicating that
α-KG–CoA hydrolysis is not an activity unique to Nit1, unlike
dGSH hydrolysis.
We also further tested the specificity of mmNit1 and of its
yeast ortholog with different amides physiologically present in
mammalian cells. No activity (< 0.001 μmol/min per milligram
protein) was detected by measuring spectrophotometrically the
formation of glutamate from L-glutamine, γ-L-glutamyl-e-L-lysine,
N-acetyl-aspartylglutamate, or N-acetylglutamate (all tested at
1-mM concentration in the presence of 500 nM enzyme). A very
low activity was, however, detected with 1 mM GSH as a sub-
strate (Table 4).
Presence of dGSH Amidases and ω-Amidases in Bacteria. BLAST
searches indicated that several enteriobacteriaceae, known to
contain GSH (as indicated by GSH assays or by the presence in
their genomes of both GSH synthetase and γ-glutamylcysteine
synthetase), contain two Nit1/Nit2 homologs. The homologs
from Escherichia coli, Yersinia enterocolitica, and Pseudomonas
aeruginosa were expressed in recombinant form and their activity
toward dGSH and α-KGM was tested using a fixed concentration
(80 μM) of these substrates. One of the two homologs (YafV in
the case of E. coli) showed high activity toward α-KGM and
almost no detectable activity toward dGSH, whereas the other
homolog (YbeM in the case of E. coli) showed higher activity
with dGSH than with α-KGM. The ratio of the two activities
indicates that the E. coli enzyme is about as specific as mouse
mmNit1 and scNit1, whereas the enzymes of P. aeruginosa (paNit1)
and Y. enterocolitica (yeNit1) are less specific (Table 4).
Similar assays performed on the single Nit1/Nit2 homolog
present in the cyanobacterium Synechocystis, which like other
cyanobacteria contains the GSH synthesizing enzymes, indicated
that it acted on both dGSH and α-KGM, with a ratio of activities
of only 3.4. In contrast, the single homologs present in Bifido-
bacterium longum and in Staphylococcus aureus, which have no
GSH synthetase, showed higher activity toward α-KGM, most
particularly in the case of the S. aureus enzyme, which was
∼3,500-fold more active with α-KGM than with dGSH (Table 4).
Remarkably, tests performed to measure glutamate formation
from GSH or L-glutamine indicated that, as a rule, the “dGSH
amidases” had a low but detectable activity toward GSH and
no activity toward L-glutamine, while reciprocally, ω-amidases
showed a low activity toward L-glutamine, but no activity toward
GSH (Table 4). Thus, the side activities of these enzymes mir-
rored their main activities toward their physiologic, deaminated
substrates.
Fig. 3. LC/MS detection of dGSH in the urine of Nit1-deficient mice. LC/MS chromatograms showing the presence of dGSH in the urine (500-fold diluted) of a
Nit1-KO mouse (red line) and a WT mouse (green). The blue chromatogram refers to urine from a WT mouse spiked with 25 μM purified dGSH. (Inset)
MS2 spectrum of dGSH found in the Nit1-KO urine sample, mirrored with the MS2 spectrum generated from the standard.
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Discussion
Nit1 and Its Yeast Ortholog Hydrolyze dGSH. The role of Nit1 has
remained a conundrum, despite intensive studies on this enzyme,
including several structural studies (1–6, 23, 31). The results
presented here are in agreement with the crystal structure of the
yeast Nit1 ortholog, scNit1, which included a GSH-like molecule
bound at the active site (31). The crystallized enzyme (catalytically
inactivated by the replacement of Cys169 with Ala) had been
expressed in E. coli (31), which produces GSH. The metabolite
repair concept led us to consider the possibility that the substrate
of Nit1 may be indeed a modified form of GSH, resulting from
minor side activities of transaminases. This hypothesis has been
borne out by the overall results of the present study.
The data obtained with purified recombinant enzymes show
that, among the potential substrates that we tested, dGSH is by
far the best for Nit1. Furthermore, our results with human Nit1-
KO cells and with Nit1-KO mice indicate that dGSH is used by
the mammalian Nit1 and its yeast ortholog in vivo. Because it is
customary to name enzymes after their best substrate, we pro-
pose for Nit1 and its orthologs the name “dGSH amidases.” This
is not meant to imply that Nit1 does not act on other substrates,
but these are most likely quantitatively less important than
dGSH (see below). For example, the fact that mmNit1 and
mmNit2 display similar activities toward α-KG–CoA, but dras-
tically different activities toward dGSH, suggests that the evo-
lutionary pressure allowing the conservation of Nit1 and its
orthologs is based on their capacity to hydrolyze dGSH.
Structural Features Differentiating dGSH Amidases from ω-Amidases.
Given their high sequence similarity, it is worthwhile to analyze
the features that contribute to the substrate specificities of
dGSH amidases and ω-amidases. We show in SI Appendix, Fig.
S14A an alignment of all 13 amidases that have been investigated
and a phylogenetic tree that was constructed from this align-
ment. Remarkably, the enzymes that act preferentially on dGSH
and those that act preferentially on α-KGM do not generate two
distinct branches (SI Appendix, Fig. S14B): the B. longum enzyme
blYbeM acts best on α-KGM, whereas its most similar homolog,
E. coli YbeM, hydrolyzes dGSH 500-fold better than it does with
α-KGM. We noted also from pairwise sequence alignments that
mouse ω-amidase (mmNit2) shows a higher degree of identity
with mouse or yeast dGSH amidases (35% and 31% identity with
mmNit1 and scNit1) than with its E. coli ortholog (26% identity
with ecYafV). This finding suggests a complex evolutionary
history of the Nit1/Nit2 family, where specialization toward en-
zymes acting as ω-amidases or dGSH amidases may have occurred
more than once through convergent evolution. Such a pattern is
not surprising considering the intricate history of GSH, which
appears to have been “invented” on distinct occasions during
evolution (32, 33).
Inspection of the alignment shows that, as expected, all
13 sequences share the catalytic triad (highlighted in yellow)
typical of enzymes of the Nit1/Nit2 family (Glu45-Lys127-
Cys169, according to the scNit1 numbering). Furthermore, they
all share residues (highlighted in cyan) that interact with the
α-KG (or oxaloacetyl) moiety of the substrates (SI Appendix, Fig.
S15), most particularly: (i) an Arg residue (Arg173) located four
positions after the catalytic Cys; the guanidino group of this Arg
interacts with the α-carboxylic group of α-KGM or dGSH in
scNit1 (31); (ii) a Phe or Trp (Phe195 in scNit1) ∼ 25 residues
downstream of the catalytic Cys; this residue interacts via π–π
interaction with the keto group of α-KG in scNit1 (31), thus
impeding recognition of substrates (e.g., GSH in Nit1, L-glutamine
in Nit2) where the keto group is replaced by a protonated amine.
As stated in the introduction, a major discriminant between
Nit1 and Nit2 is the size of the subpocket where the amido group
of α-KGM is predicted to bind. This subpocket is much smaller
in mmNit2 (SI Appendix, Fig. S15) because of the presence of
Tyr87 and Tyr254 (magenta in SI Appendix, Fig. S15) (31). The
first of these two residues is highly conserved in highly specific
ω-amidases; the second residue is also conserved, if one allows
for a shift of two positions in the “YafV”-type of ω-amidases (SI
Appendix, Fig. S14A). We propose that these two residues are a
signature for ω-amidases.
Fig. 4. GC/MS detection of a dGSH derivative in the urine of Nit1-deficient
mice. Urine samples were treated with the TMS reagent BSFTA/TMCS [N,
O-bis(trimethylsilyl) trifluoroacetamide-trimethylchlorosilane] (SI Appendix,
Supplementary Materials and Methods). (A) GC/MS total ion current chro-
matogram showing the presence of a major peak (with retention time
11.97 min and m/z 398 for the apparent molecular ion) in the urine of a Nit1-
KO mouse. The same peak was observed in all of the urine samples from Nit1-
KO mice. (B) In contrast, the peak was undetectable in the urine of control
mice. (C) GC/MS analysis of purified dGSH shows a peak with the same re-
tention time and mass spectrum (see also SI Appendix, Fig. S5), indicating that
this is a derivative of dGSH. (D) Mass spectrum of the compound present in the
urine of Nit1-KO mice. The molecular ion shifted to m/z 416 upon silylation
with N,O-Bis (trimethyl-d9-silyl)acetamide (d9-BSA) (SI Appendix, Fig. S5C), in-
dicating that the ion is M+ and contains two TMSmoieties. High-resolutionMS
indicated the elemental formula C16H26N2O6Si2 (exact mass 398.13892; calcu-
lated mass 398.13294; millimass error 5.98 and unsaturation of 7.0), implying
for the underivatized compound MW = 254 and the elemental formula C10
H10 N2 O6. The Inset shows the proposed structure for the dGSH derivative.
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Remarkably, in all dGSH amidases, the first of these two
residues is replaced by a smaller residue (Ser51 in scNit1; green
SI Appendix, Fig. S14A), which allows for a larger subpocket. The
second residue is replaced by a basic residue (Arg250 in scNit1;
green in SI Appendix, Fig. S14A), which interacts with the car-
boxylic group of the glycine moiety of dGSH (31). Strikingly, this
basic residue is conserved in all dGSH amidases, if one allows for
a one-residue shift in E. coli YbeM (SI Appendix, Fig. S14A); on
the other hand His93, also proposed to interact with the cys-
teinylglycine moiety of dGSH (31) is not conserved. We there-
fore propose that a small residue (Gly, Ala, Ser, or Asp) in the
first of the two positions and a basic residue in the second po-
sition are a signature for dGSH amidases. It is interesting to note
that the first, small residue is replaced by a large, polar residue
(Arg) in the B. longum enzyme (SI Appendix, Fig. S14A) and that
this enzyme is a good ω-amidase and a poor dGSH amidase,
unlike ecYbeM with which it clusters in the evolutionary tree.
This finding agrees with the importance of this residue for
substrate discrimination.
In SI Appendix, Table S3, we provide a list of ∼130 organisms
with indications about their potential ability to produce GSH
(as deduced from the presence of a GSH synthetase and a
γ-glutamylcysteine synthetase) and the presence of dGSH ami-
dase or ω-amidase (as deduced from similarity with the enzymes
studied in the present work, combined with the presence of the
signature residues described above). As summarized in Table 5,
most of the organisms that we investigated have both the capacity
to synthesize GSH and a putative dGSH amidase or have neither
of these. Exceptions are a couple of bacteria whose genomes
encode a putative dGSH amidase but no GSH synthetase, which
might be because of the existence of an additional form of GSH
synthetase that has not yet been identified, as was indeed pro-
posed for Rubrobacter xylanophilus and Rubrobacter radiotolerans
(34). Another exception is a significant group of species that
have the capacity to synthesize GSH while not having any dGSH
amidase. This finding suggests that this enzyme may be dis-
pensed with or that a nonhomologous enzyme catalyzes the hy-
drolysis of dGSH in some organisms. Overall, these data indicate
Table 4. Specificity of the amidase activities of Nit1/Nit2 homologs from different bacterial species compared with the mouse and
S. cerevisiae enzymes
Protein
dGSH amidase
specific activity
(μmol·min−1·mg−1)
ω-Amidase specific
activity (μmol·min−1·mg−1)
Amidase activities:
dGSH /α-KGM
Protein in
assay (nM)
GSH amidase
specific activity
(μmol·min−1·mg−1)
L-Glutaminase
specific activity
(μmol·min−1·mg−1)
mmNit1 0.804 ± 0.042 0.002 ± 0.000 530 ± 50 10/600 0.005; 0.008 <0.001
mmNit2 <0.001 7.59 ± 0.29 <0.001 500/2 <0.001 0.003; 0.002
scNit1 8.71 ± 0.13 0.004 ± 0.000 2400 ± 35 2/600 0.003; 0.002 <0.001
scNit2 <0.001 3.59 ± 0.08 <0.001 500/2 <0.001 0.044; 0.037
ecYbeM 40.63 ± 0.27 0.178 ± 0.000 503 ± 3 2/100 0.001; 0.001 <0.001
ecYafV 0.001 ± 0.000 6.65 ± 0.08 <0.001 500/2 <0.001 0.167; 0.172
yeNit1 6.50 ± 0.17 0.20 ± 0.00 33 ± 1 10/100 0.002; 0.003 <0.001
yeYafV* <0.001 21 ± 0.60* <0.001 500/2 <0.001 0.002; 0.001
paNit1 13.6 ± 0.75 1.10 ± 0.10 13 ± 0.2 10/10 0.003; 0.004 <0.001
paYafV <0.001 9.55 ± 0.08 <0.001 500/2 <0.001 0.264; 0.269
syNit1 7.77 ± 0.12 2.13 ± 0.09 3.7 ± 0.1 10/10 <0.001 <0.001
blYbeM 0.11 ± 0.00 2.44 ± 0.03 0.05 ± 0.00 100/10 <0.001 0.001; 0.000
saYafV 0.001 ± 0.000 3.87 ± 0.00 <0.001 4500/2 <0.001 0.011; 0.010
All activities were determined spectrophotometrically at 37 °C. dGSH and ω-amidase was assayed by measuring the formation of α-KG from 80 μM dGSH
(column 2) or α-KGM (column 3) as described in Materials and Methods. The concentration of enzyme used in these assays is indicated (column 5) for dGSH
amidase (first value) and ω-amidase (second value). GSH amidase and L-glutaminase activities were determined spectrophotometrically by the production of
L-glutamate from 1 mM GSH or L-glutamine.
*Because of its instability at pH 8.5, all assays with this protein were performed at pH 7.2 (50 mM potassium phosphate).
Table 3. Slow GSH transaminations carried out by five different mammalian transaminases
Enzyme
Amino group donor →
Amino group acceptor (3 mM) ↓
Activity (turnovers·min−1)
GSH (15 mM) L-Gln (1 mM) L-Glu (1 mM) L-Orn (1 mM)
KYAT1 Glyoxylate 0.17 ± 0.05 42 ± 4 <0.1 —
4-Methylthio-2-oxobutyrate 0.049 ± 0.003 130 ± 7 <0.1 —
PSAT1 Glyoxylate 0.53 ± 0.14 1.2 ± 0.4 10 ± 2 —
Oxaloacetate 0.17 ± 0.01 5.7 ± 0.8 23 ± 1 —
GOT1 Glyoxylate 0.018 ± 0.003 0.23 ± 0.02 0.40 ± 0.02 —
Oxaloacetate 0.012 ± 0.002 7.8 ± 0.7 686 ± 72 —
KYAT3 Glyoxylate 0.04 ± 0.02 51 ± 3 ≤0.1 —
4-Methylthio-2-oxobutyrate 0.012 ± 0.003 25 ± 2 ≤0.1 —
OAT Glyoxylate 0.27 ± 0.06 ≤0.1 5.0 ± 0.5 3.3 ± 0.2
α-KG — — — 187 ± 4
Activities are expressed as number of turnovers per active site per minute, and are the average (± SEM) of
at least three separate measurements. The five recombinant transaminases examined in this table are: human
glutamine transaminase K [KYAT1; the cytosolic form was tested (27)]; human phosphoserine aminotransfer-
ase (PSAT1; cytosolic); human cytosolic aspartate aminotransferase (GOT1); mouse glutamine transaminase
L (KYAT3; the cytosolic form was tested); mouse ornithine aminotransferase (OAT; mitochondrial). Enzymatic
assays are described in Materials and Methods.
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that dGSH amidases are largely distributed in GSH-containing
organisms, and extremely rare in others (Table 5).
Nit1 Is Useful to Correct the Unspecific Activity of Transaminases
Toward GSH. GSH is one of the most abundant intracellular
carriers of an α-amino group. Amino acids are usually present at
much lower concentrations, except for glutamate and glutamine.
It is therefore not surprising that GSH may be the subject of
significant side-reactions.
Transaminases are also abundant cellular enzymes, localized
mostly in the cytosol and in the mitochondria. We have tested
several transaminases (both cytosolic and mitochondrial) and
found that all of them possess some ability to produce dGSH. In
other words, the incidental production of dGSH seems to be a
feature shared by many transaminases and at least one decar-
boxylase (35). We use the term incidental, because the observed
reaction efficiencies are remarkably small (Table 3). However,
even reaction rates of such a modest order of magnitude can
become very significant over time, especially when there is ample
availability of substrate, as is the case for intracellular GSH.
Besides these considerations, several pieces of circumstantial
evidence from model cells and animal systems support a scenario
in which the formation of dGSH arises from the “mistaken”
reactions of transaminases and that Nit1, by degrading dGSH,
fulfills the role of a metabolite repair enzyme.
First, the observation that AOA, a general inhibitor of trans-
aminases, limits the accumulation of dGSH is consistent with the
idea that transamination is the major route for dGSH formation
in vivo. In principle, dGSH could also be formed through oxi-
dative deamination of GSH, in particular by IL4I1, the mam-
malian enzyme equivalent to snake venom L-amino acid oxidase.
However, expression of this enzyme is exquisitely specific for
cells of the immune system and is under the control of IL-4 (36),
making it unlikely that IL4I1 can be a main producer of dGSH.
Second, Nit1 is found in the “right” places. We have shown
that the mammalian Nit1 is located in both the cytosol and the
mitochondria, the two subcellular environments where dGSH-
forming transaminases are mainly localized. Additionally, ex-
pression of Nit1 is particularly high in the liver and kidney (23),
where transaminase expression is also most abundant.
Third, there is no known metabolic use for dGSH, which in
fact is excreted in substantial amounts by Nit1-KO mice. In con-
trast, the products of the Nit1 reaction (α-KG and cysteinylglycine)
are readily metabolized (37). These observations are consistent
with dGSH representing a “waste” compound, which may require a
repair enzyme to be recycled into metabolites useful for the cell.
In principle, transaminations where GSH is the amino group
donor could afford the same advantage as transaminations with
glutamine. In fact, both processes are essentially irreversible,
because the products that are formed cyclize and because they
are hydrolyzed by an amidase: Nit2 (in the case of α-KGM) or
Nit1 (in the case of dGSH). The metabolic disadvantage of the
pathway involving GSH is that resynthesizing GSH from dGSH
would cost two ATP molecules compared with one for regen-
erating glutamine through the glutamine synthase reaction.
Furthermore, if transamination reactions with GSH were highly
active, the intracellular levels of cysteinylglycine and of its hy-
drolysis product cysteine might rise substantially. Because cys-
teine is more reactive and more toxic than is GSH (38), this
would represent a liability for the cell.
There has obviously been a counter-selection during evolution
to avoid GSH being used as a standard substrate for trans-
amination. Nevertheless, the very presence of Nit1, which can
“correct” the formation of dGSH, may conceivably limit the
evolutionary pressure for transaminases to achieve an even greater
discrimination against GSH, potentially explaining why so many
enzymes retain some marginal ability to form dGSH.
It is likely that transaminases catalyze side reactions toward
other γ-glutamyl-amino acids or γ-glutamyl-amines that are
formed by transglutamylation reactions using GSH as a donor
(39). It would be interesting to determine whether the variety of
α-KG derivatives that might be formed in this way is processed by
Nit1 and its functional orthologs. However, given the abundance
of GSH, it is likely that these other potential derivatives are only
of minor importance.
Considerations Concerning the Biological Importance of Nit1. The
present work establishes a clear link between Nit1 enzyme ac-
tivity and the metabolism of GSH. The distribution of Nit1
orthologs in disparate (but GSH-producing) organisms attests to
the biological importance of the dGSH amidase function and
strongly implies that this function provides significant selective
advantages. On the other hand, both Nit1-deficient cells and
mice do not show any dramatic phenotype, raising the question
as to what these advantages can be.
GSH has many recognized functions (40): these include roles
as an antioxidant (and as a cofactor for the neutralization of
peroxides and related products generated by reactive oxygen
species), in the detoxification of xenobiotics, in metal homeo-
stasis, and as a preferred form of cysteine storage and transport.
In effect, GSH can be regarded as a “protected,” more stable
form of cysteine (e.g., less prone to autooxidation) (41).
An obvious advantage of having a dGSH amidase is therefore
to avoid the loss of GSH (and hence of L-cysteine); this can be
best appreciated by considering the case of the mammalian en-
zyme. If the levels of dGSH excretion observed in mice (we
consider here the lowest estimate, 687 μmol·mmol creatinine−1)
were applicable to humans, a 70-kg individual deficient in Nit1
would excrete daily about 2.2 g of GSH as dGSH. Such an
amount corresponds to ∼15% of total body GSH. By compari-
son, individuals with γ-glutamyl transpeptidase deficiency were
reported to eliminate in urine up to 1 g GSH per day (42).
Given the high rate at which GSH is turned over, this drain of
GSH may be overcome and cause no harm under most condi-
tions. Indeed, the accumulation of dGSH in Nit1-KO cell models
does not appear to significantly affect the GSH levels in the same
cells (Fig. 2). However, it seems reasonable to hypothesize that
the depletion of GSH may be less sustainable in cells particularly
rich in transaminases or in times when the GSH demand is high.
In addition to this hypothesis, the accumulation of dGSH might
also subtly alter some cellular functions. For example, because
there are many enzymes (including oxidoreductases and glutathione
Table 5. Occurrence of dGSH amidase and GSH synthetase in
133 representative organisms
GSH
synthetase
dGSH
amidase
No. of
instances Examples
+ + 38 Danio rerio, Drosophila
melanogaster, Arabidopsis
thaliana, and many proteobacteria
and cyanobacteria
— + 2 Anaeromyxobacter dehalogenans,
Salinispora arenicola
+ — 19 Trypanosoma brucei, Buchnera
aphidicola, Xylella fastidiosa
— — 62 Encephalitozoon intestinalis,
Haemophilus influenzae,
Haemophilus pylori
+ Dubious 2 Bradyrhizobium japonicum
— Dubious 11 Arthrobacter alpinus
Summary of the data presented in SI Appendix, Table S3, which comprises
eukaryotes, eubacteria, and archaea.
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S-transferases) that use GSH as a substrate, dGSH may poten-
tially interfere with the function of at least some of them. In the
long term, these phenomena may represent a sizable selective
disadvantage for the Nit1-deficient organisms.
Nit1 was classified as a tumor suppressor because of its asso-
ciation with the fragile histidine-triad protein Fhit. In fact,
whereas Nit1 and Fhit are discrete proteins in mammals, they are
expressed as fused domains in widely distant invertebrates such
as nematodes, insects, arthropods, and flatworms (2, 23). Fhit
proteins act best to hydrolyze adenyl-derivatives, such as ApppA
and AppppA (1, 2). However, we do not see any obvious con-
nection between the enzymic functions of Fhit and of Nit1. We
must also stress that, although data collected in mammalian cells,
mice models, and human samples suggest that Nit1 promotes
apoptosis (23) and affects, in a complex fashion, the develop-
ment and progression of some types of tumors (23, 43), it is
uncertain whether these roles bear any connection with the en-
zyme’s catalytic function. In fact, mutation of the conserved ac-
tive site cysteine to an alanine did not alter the ability of Nit1 to
promote apoptosis in human cells (23). Perhaps related to
the above, a recent study reported that Nit1 can interact with
β-catenin, repressing β-catenin–mediated transcription, and that
this repressive activity is not affected by mutation of the catalytic
cysteine (44). It is therefore possible that the Fhit–Nit1 con-
nection may reflect other (as yet unclearly defined) Nit1 func-
tions that do not depend on the catalytic hydrolysis of dGSH.
Concluding Remarks
The results presented here establish Nit1 as a new example of a
highly conserved enzyme with a metabolite repair role. Further
work will be needed to understand why the dGSH amidase ac-
tivity of Nit1 is important. Is it because dGSH exerts some toxic
effects in the cells or is it to recycle precious building blocks? In
any case, this work suggests that, when addressing the function of
the numerous putative enzymes encoded by the human and other
genomes, their possible involvement in metabolite repair should
be seriously considered. The enormous chemical diversity that
side reactions add to the metabolome makes this search for
enzymic function both more challenging and more interesting.
Materials and Methods
Materials and other methods used in this work are mainly provided in the
SI Appendix. All procedures involving mice were performed following pro-
tocols approved by the Ohio State University Institutional Animal Care and
Use Committee.
Cloning, Overexpression, and Purification of Recombinant Proteins. His6-tag-
ged (mouse) mmNit1 (lacking the targeting peptide sequence) and
mmNit2 were expressed as reported earlier (5). The human cytosolic trans-
aminases, glutamine transaminase K (KYAT1; previously CCBL1), aspartate
aminotransferase (GOT1), and phosphoserine aminotransferase (PSAT1)
were expressed as described previously (25). The coding sequences of the
yeast Nit1 and Nit2 orthologs (encoded by the NIT2 and NIT3 genes, re-
spectively), and of the bacterial homologs shown in Table 1, with the ex-
ception of ecYafV and blYbeM, were PCR-amplified from genomic DNA,
cloned in the pET28a vector, and expressed as recombinant proteins
(N-terminal His6 tag) in E. coli BL21(DE) cells. ecYafV was expressed from an
ASKA clone (45) and blYbeM was produced using a pET28A plasmid con-
taining a codon optimized synthetic sequence (GenScript). The coding se-
quences of mouse ornithine transaminase (OAT) and glutamine transaminase
L (official gene symbol KYAT3; previously CCBL2) were PCR-amplified from
mouse cDNA and cloned into expression vectors (pET28a and pET24, re-
spectively); the proteins were then expressed in recombinant form in E. coli
BL21(DE) cells. Details of (i) the primers used for PCR amplification, (ii) the
restriction enzymes used for cloning, and (iii) the culture conditions adopted
for the overexpression of individual proteins are provided in SI Appendix,
Supplementary Materials and Methods. Preparation of bacterial homoge-
nates and purification of recombinant proteins by metal-affinity chroma-
tography (HisTrap columns) were carried out as previously described (46).
Purified proteins were finally kept in 25 mM Hepes, pH 7.2, 300 mM NaCl,
1 mM DTT, and 10% (vol/vol) glycerol, and stored at −70 °C until use.
Production of HAP1 Cell Lines Deficient in Nit1 and Nit2 by CRISPR/Cas9. The
human-derived HAP1 cell line (Horizon Discovery) expresses both the Nit1 and
the Nit2 genes, as described by the number of transcripts per kilobase million
for Nit1 (13.85; https://www.horizondiscovery.com/human-nit1-knockout-cell-
line-hzghc4817) and for Nit2 (53.21; https://www.horizondiscovery.com/human-
nit2-knockout-cell-line-hzghc56954). The parental cells were therefore used
to create HAP1 cell lines deficient in either Nit1 or Nit2 by the CRISPR/
Cas9 technology (details provided in SI Appendix, Supplementary Materials
and Methods).
The clones we ultimately selected for further studies presented the fol-
lowing modifications in the Nit1 or Nit2 genes: for Nit1-T1, a 13-bp deletion,
leading to a change in reading frame after the codon for Val-71 and a
premature stop 18 codons later; for Nit1-T2, a >190-bp insertion after the
codon for Asn179, which also leads to a premature stop after about 40 co-
dons; finally, for NIT2, an 80-bp insertion after Glu64, with a premature stop
after 20 codons.
Preparation of Amidase Substrates. α-KGM was prepared by oxidation of
L-glutamine by snake venom L-amino acid oxidase, as previously described
(5). dGSH and dOA were prepared by an analogous procedure. Briefly, a
200-mM solution of GSH or OA, adjusted to pH 7, was incubated overnight
at 37 °C under agitation with 4 units/mL of catalase and 2 mg/mL of Crotalus
adamanteus L-amino acid oxidase (Sigma). After incubation, the reaction
mixture for the preparation of dGSH was usually supplemented with solid
DTT (∼120 mM final) to reduce the disulfide adducts. The mixture was then
deproteinized by addition of HClO4 to a final concentration of 3% and
centrifuged at 15,000 × g for 15 min at 4 °C. A first purification of the
products from reagents was accomplished by applying the supernatant to a
5 mL AG50 cation-exchange column, equilibrated with 0.1 M HCl. The eluate
was neutralized with 3 M K2CO3, and the KClO4 precipitate was removed by
centrifugation. dGSH and dOA were further purified by HPLC from a 19 ×
150 mm XBridge Prep C18 column (Waters), by isocratic elution with 3%
aqueous acetonitrile/0.1% trifluoroacetic acid at a flow rate of 20 mL/min.
Both reduced dGSH (m/z 307, detected as [MH]+) and dOA (m/z 289) eluted
in two adjacent peaks of similar areas, attributable to the two anomeric
forms of the cyclized ketoacids. This finding was supported by the obser-
vation that the compounds in both peaks were substrates for Nit1.
ω-Amidase Assay. The reaction of mmNit2 and its orthologs was monitored
through a coupled assay with GDH (5). Measurement of this reaction is
complicated by the fact that α-KGM essentially exists in cyclic forms, which at
equilibrium are about 300 times more abundant than the linear form. The
rate of equilibration between the cyclic and linear structure is pH-
dependent, being faster at alkaline pH. As only the open form appears to
be a substrate for mmNit2 (5, 20), the ω-amidase reaction was measured at
pH 8.5 and using very diluted enzyme (1–2 nM). The reaction mixture (1-mL
final volume) contained 50 mM Bicine (pH 8.5), 50 mM KCl, 0.5 mg/mL BSA,
2 mM DTT, 0.22 mM NADH, 5 mM ammonium acetate, 2.4 units/mL GDH, as
well as the amidase. These assays were performed at 30 °C (results shown in
Table 2) or 37 °C (results shown in Table 4). Under these conditions, the
measured activity increased linearly with ω-amidase concentration, indicat-
ing that the reaction was not rate-limited by opening of the cyclic form of
α-KGM. The range of α-KGM concentrations tested was 40–1,500 μM.
dGSH Amidase Assay. Release of α-KG from dGSH and dOA by Nit1 and its
orthologs was measured through a coupled assay with GDH, analogous to
the ω-amidase assay. The reaction mixture (1 mL) contained 50 mM buffer
(Bicine or Hepes), 50 mM KCl, 0.5 mg/mL BSA, 2 mM DTT, 0.22 mM NADH,
5 mM ammonium acetate and 2.4 units/mL GDH. These assays were per-
formed at 30 °C (results shown in Table 2) or 37 °C (results shown in Table 4).
When these reactions were performed to determine the enzyme catalytic
parameters with dGSH, the buffer used was Bicine pH 8.5 and the concen-
tration of the amidase enzyme was maintained in the range 10–40 nM
(mmNit1) or 10–20 nM (scNit1). Under these conditions, the measured ac-
tivity depended linearly on amidase concentration, indicating that the pro-
cess was not rate-limited by opening of the cyclic form of the substrate. The
range of dGSH concentrations tested was 15–330 μM.
GSH and Other Transamination Assays. Transaminases (1–5 μM) were in-
cubated for up to 24 h at 30 °C, in the presence of GSH (5 or 15 mM) and of
an appropriate amino group acceptor in 50 mM Bicine buffer pH 8.5, 50 mM
KCl, 0.5 mg/mL BSA, 2 mM DTT. The final volume of the reaction mixture was
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typically 0.6 mL. At given times, aliquots (120 μL) were taken from the re-
action mixture and heated at 100 °C for 5 min to stop the reaction. The
protein precipitate was removed by centrifugation and the content of dGSH
in the aliquot was assessed spectrophotometrically through the coupled
Nit1-GDH assay described above. Other transaminase assays shown in Table
3 are described in SI Appendix, Supplementary Materials and Methods.
Other Specificity Assays. The GSH amidase and the L-glutaminase activities
of all amidases (shown in Table 4) were tested in the presence of 1 mM
substrate by measuring spectrophotometrically at 37 °C the formation of
glutamate. The reaction mixture (1-mL final volume) contained 50 mM
Bicine (pH 8.5), 50 mM KCl, 0.5 mg/mL BSA, 2 mM DTT, 0.2 mM NAD+,
0.5 mM ADP-Mg, 3.5 units/mL GDH, as well as the amidase (100–500 nM).
The amidase activity (glutamate producing) of mmNit1 and scNit1 (500 nM
in the assay) toward 1 mM γ-L-glutamyl-e-L-lysine, N-acetyl-aspartylglutamate
or N-acetylglutamate was tested using the same assay.
LC/MS Analyses. Full scans (307–312 m/z) for monoisotopic mass detection
and natural isotope distribution, selected ion monitoring (307.06 m/z and
308.09m/z for dGSH and GSH, respectively, using a measurement window of
0.5m/z) for absolute and relative quantification, and parallel reactionmonitoring
(307.06 m/z and 308.09 m/z parent ions, respectively, detecting 50–300 m/z
fragments) were performed on all samples in separate runs. Standards were
prepared in a matrix as close to the samples as possible. For the analysis of yeast
andmammalian cell extracts, standard curves of GSH and dGSHwere prepared in
LC/MS grade water:MeOH (50:50). For the analysis of mouse urine, dGSH stan-
dard curves were prepared in urine from a WT mouse. Details on the instrument
used, type of column, and separation protocols for GSH and dGSH determination
are provided in SI Appendix, Supplementary Materials and Methods.
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